Similar articles

• An apparently immunoregulatory effect of human leukocyte interferon on the blastogenic response in Down's syndrome.

  Hahn T, Levin S, Handzel ZT, Ashkenazi A, Chemke J, Shterk V. Hahn T, et al. Isr J Med Sci. 1979 Sep;15(9):775-8. Isr J Med Sci. 1979. PMID: 159876 No abstract available.
• Effect of human interferon preparations on lymphoblastogenesis in Down's syndrome.

  Cupples CG, Tan YH. Cupples CG, et al. Nature. 1977 May 12;267(5607):165-7. doi: 10.1038/267165a0. Nature. 1977. PMID: 16073432
• Enhancing effect of lithium and potassium ions on lectin-induced lymphocyte proliferation in aging and Down's syndrome subjects.

  Licastro F, Chiricolo M, Tabacchi P, Barboni F, Zannotti M, Franceschi C. Licastro F, et al. Cell Immunol. 1983 Jan;75(1):111-21. doi: 10.1016/0008-8749(83)90310-6. Cell Immunol. 1983. PMID: 6297805
• T-lymphocyte function and sensitivity to interferon in trisomy 21.

  Epstein LB, Epstein CJ. Epstein LB, et al. Cell Immunol. 1980 May;51(2):303-18. doi: 10.1016/0008-8749(80)90262-2. Cell Immunol. 1980. PMID: 6154538 No abstract available.
• Functional implications of gene dosage effects in trisomy 21.

  Epstein CJ, Epstein LB, Cox DR, Weil J. Epstein CJ, et al. Hum Genet Suppl. 1981;2:155-72. doi: 10.1007/978-3-642-68006-9_12. Hum Genet Suppl. 1981. PMID: 6185454 Review. No abstract available.